Lupin reported a strong third quarter performance. Its revenue increased by 28% to ₹7,167 crore from ₹5,618.6 crore in the previous year. Its margins expanded to 31.6% from 21.5% in the previous year.
Lupin Share Price Target: A key focus area for Lupin remains its US business, which the company expects to strengthen further. Management indicated that US revenues are likely to exceed USD 1 billion ...
Stocks to BUY, SELL or HOLD Today: Brokerages recommend BUY on L&T and AB Capital, while suggesting NEUTRAL on Lupin, based on growth outlook, valuations and segment performance ...
Single-day regimen of palonosetron (PALO) and dexamethasone (DEX) for the prevention of emesis associated with moderately emetogenic chemotherapy (MEC): Subgroup analysis from a randomized phase III ...